Structure Info
- Chemspace ID
- CSSS00159268927 (In-Stock Screening Compounds)
- MFCD
- MFCD11840616
- IUPAC Name
- (2R,3S,6E,11R,15S,17R)-6-{[bis(prop-2-en-1-yl)amino]methylidene}-8-hydroxy-3-(methoxymethyl)-2,15-dimethyl-5,9,14-trioxo-4-oxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(10),7-dien-17-yl acetate
- Mol formula
- C29H35NO8
- Mol weight
- 526 Da
- Catalog Number(s)
- 140544, AA00DA8M, AG00DABE, AG19698, AGN-PC-0S7BQF, AR00DB0E, BP162743, CSC159268927, D395242, G13771, HY-N6775, LAN-B46763, MS-29730, T16908
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.51
- Heavy atoms count
- 38
- Rotatable bond count
- 9
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.517
- Polar surface area (Å)
- 119
- Hydrogen bond acceptors count
- 7
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSS00159268927
Items Overall 6 items from 2 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
MedChemExpress | 10 days | United States To: | 99 | 5 mg | 360 | |
MedChemExpress | 10 days | United States To: | 99 | 10 mg | 576 | |
MedChemExpress | 10 days | United States To: | 99 | 10mM/1mL | 416 | |
Description: Names: Sonolisib; PX-866; Product Description: Sonolisib (PX-866), an improved Wortmannin analogue, is an oral, irreversible, and pan-isoform inhibitor of PI3K ( IC 50 =0.1 nM (p110α), 1.0 nM (p120γ), 2.9 nM (p110δ)). Antitumor activity .; Target: PI3K; CAS: 502632-66-8 | ||||||
MedChemExpress EU | 10 days | Sweden To: | 99 | 5 mg | 379 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10 mg | 607 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10mM/1mL | 439 | |
Description: Names: Sonolisib; PX-866; Product Description: Sonolisib (PX-866), an improved Wortmannin analogue, is an oral, irreversible, and pan-isoform inhibitor of PI3K (IC50=0.1 nM (p110α), 1.0 nM (p120γ), 2.9 nM (p110δ)). Antitumor activity; Target: PI3K; CAS: 502632-66-8 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire